The embolization of the neuroendovascular aneurysm assisted by robotic shows promising results of 6 months

The monitoring results of six months of the pioneering test of the embolization of the neuroendovascular aneurysm assisted by robotic were presented today by Vitor Pereira, MD on behalf of the researchers of the annual meeting of the Neuro -Intervention Surgery Society (SNIS).

The six -month awarded results of the prospective study, of a single arm, international, multicentric and not inferiority demonstrated security and effectiveness of the embolization of the neuroendovascular aneurysm assisted by robotics. These results represent a significant milestone, since they constitute the only clinical follow -up data published in the middle of the period to date on the embolization of neuroendovascular aneurysm assisted by robotic.

The study registered 117 patients in 10 clinical sites and was performed by 14 neurointerministas that covered six countries. It included both a study prior to the market in Canada and in studies after the market in Australia, Austria, France, Spain and Switzerland.

The key findings of the study include:

A 94%technical success rate, achieving the final point of primary effectiveness defined as the successful completion of the neuroendovascular procedure assisted by robotic without unplanned conversions to manual intervention. Immediate complete occlusion (Rroc 1) of 64.5% increased to 94.1% at six months. Favorable clinical results were observed (modified rankin scale score 0–2) in 98.9% (87/88) of patients at six months.

“The six -month results of the Corpath Grx trial represent a significant step in the evolution of neuroendovascular robotics and will play a key role in the configuration of future innovation in the field of neuroendovascular therapy. I am excited to share this news with the community,” said Dr. Pereira. “It shows that robotics in neuroendovascular interventions could provide precision and support to the doctor even to navigate in tortuous anatomy and treatment of complex aneurysm cases.”

The Corpath Grx essay assisted by neuroendovascular robotic was sponsored by Siemens Healthineers endovascular robotics, Inc. Siemens Healthineers continues to invest in the development of its next generation neurendovascular robotic platform.